Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Antimicrobial Agents and Chemotherapy|March 27, 2019
Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?Christine Sekaggya-Wiltshire, Maxwell Chirehwa, Joseph Musaazi, et al.
BMC Medical Informatics and Decision Making|February 27, 2022
Willingness to pay for an mHealth anti-retroviral therapy adherence and information tool: Transitioning to sustainability, Call for life randomised study experience in UgandaAgnes Bwanika Naggirinya, Eunice L Kyomugisha, Maria S Nabaggala, et al.
AIDS (London, England)|May 7, 2026
Risks and possible implications of weight gain after switch to dolutegravir- in a large Ugandan cohort of people living with HIVEva Laker Agnes Odongpiny, Brian Otaalo, Joseph Musaazi, et al.
BMC Infectious Diseases|November 14, 2021
Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in UgandaAdelline Twimukye, Miriam Laker, Eva Agnes Laker Odongpiny, et al.
BMC Medical Education|June 17, 2026
Strengthening capacity for clinical trial monitoring in the East African community: a multi-country training programmeBelinda Twesigye, Mathius Amperiize, Steve Wandiga, et al.
The New England Journal of Medicine|July 21, 2021
Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIVNicholas I Paton, Joseph Musaazi, Cissy Kityo, et al.
Pageof 22